OPTIMI HEALTH CORP. (8BN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has a cash flow conversion efficiency ratio of -0.127x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-636.99K ≈ $-744.70K USD) by net assets (€5.02 Million ≈ $5.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 8BN net asset quality index to measure how much of total assets are equity-financed.
OPTIMI HEALTH CORP. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how OPTIMI HEALTH CORP.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can OPTIMI HEALTH CORP. service its debt to assess how comfortably operating cash covers total debt obligations.
OPTIMI HEALTH CORP. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OPTIMI HEALTH CORP. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fidelity Special Values
LSE:FSV
|
0.010x |
|
Sparc Technologies Ltd
AU:SPN
|
-0.290x |
|
Vereinigte Filzfabriken AG
MU:VFF
|
N/A |
|
SIAV S.P.A.
F:F4U
|
N/A |
|
Nexus Minerals Ltd
AU:NXM
|
-0.347x |
|
Sporting Clube de Braga - Futebol SAD
LS:SCB
|
-0.342x |
|
Salee Colour Public Company Limited
BK:COLOR
|
0.066x |
|
J.ESTINA Co.Ltd
KQ:026040
|
-0.146x |
Annual Cash Flow Conversion Efficiency for OPTIMI HEALTH CORP. (2022–2025)
The table below shows the annual cash flow conversion efficiency of OPTIMI HEALTH CORP. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see OPTIMI HEALTH CORP. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €6.57 Million ≈ $7.68 Million |
€-2.63 Million ≈ $-3.07 Million |
-0.400x | +10.56% |
| 2024-09-30 | €9.58 Million ≈ $11.20 Million |
€-4.28 Million ≈ $-5.01 Million |
-0.447x | -64.02% |
| 2023-09-30 | €13.21 Million ≈ $15.44 Million |
€-3.60 Million ≈ $-4.21 Million |
-0.273x | +4.63% |
| 2022-09-30 | €16.02 Million ≈ $18.73 Million |
€-4.58 Million ≈ $-5.35 Million |
-0.286x | -- |
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more